Clinical implication of DNMT3A and DNMT3B was obtained by the comparison of clinical/laboratory characteristics of the AML patients between two groups divided based on median level of DNMT3A and DNMT3B transcript (Table 1). Here, DNMT3A is linked to acute myeloid leukemia.